查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1552718

非人类灵长类动物市场的病毒载体（载体类型：腺病毒载体、腺相关载体、逆转录病毒载体、慢病毒载体和其他载体）- 全球产业分析、规模、份额、成长、趋势和预测，2024 -2034 年

Viral Vectors for Non-human Primates Market (Vector Type: Adenoviral Vectors, Adeno-associated Vectors, Retroviral Vectors, Lentiviral Vectors, and Other Vectors) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 253 Pages | 商品交期: 2-10个工作天内

价格

非人类灵长类动物市场的病毒载体 - 报告范围

TMR 关于全球非人灵长类病毒载体市场的报告研究了过去和当前的成长趋势以及获得 2024 年至 2034 年预测期内市场指标的宝贵见解的机会。人灵长类动物病毒载体市场，以2024年为基准年，2034年为预测年。该报告也提供了2024年至2034年全球非人灵长类病毒载体市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解非人类灵长类动物市场的病毒载体。

市场概况
2023年市场价值 1.458 亿美元
2034 年市场价值 4.299 亿美元
复合年增长率 10.5%

该报告深入研究了全球非人灵长类动物市场病毒载体的竞争格局。已经确定了全球非人类灵长类动物病毒载体市场的主要参与者，并且对每个参与者的各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球非人灵长类动物病毒载体市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034 年全球市场分析与预测

第 5 章：关键见解

  • 病毒载体技术的最新进展
  • 波特五力分析
  • 提供非人类灵长类动物临床前测试服务的领先 CRO 名单
  • 大环境分析
  • 重要产业活动（产品核准、合作伙伴关係和协作）

第 6 章：全球市场分析与预测：按向量类型

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年向量类型市场价值预测
    • 腺病毒载体
    • 腺相关载体
    • 逆转录病毒载体
    • 慢病毒载体
    • 其他的
  • 按向量类型分類的市场吸引力

第 7 章：全球市场分析与预测：按非人灵长类动物类型

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年非人类灵长类动物类型市场价值预测
    • 狨猴
    • 恒河猴
    • 食蟹猴
    • 其他的
  • 按非人类灵长类动物类型分類的市场吸引力

第 8 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按应用分類的市场价值预测
    • 基因治疗
    • 疫苗研究
  • 按应用分類的市场吸引力

第 9 章：全球市场分析与预测：按治疗领域

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年治疗领域市场价值预测
    • 遗传性疾病
    • 传染病
    • 肿瘤疾病
    • 其他的
  • 按治疗领域分類的市场吸引力

第 10 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年最终用户市场价值预测
    • 製药和生物技术公司
    • 学术研究机构
  • 最终用户的市场吸引力

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按地区分類的市场吸引力

第 12 章：北美市场分析与预测

  • 我们
  • 加拿大

第 13 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区

第 14 章：亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 15 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 16 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第17章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司市占率分析 (2023)
  • 市场足迹分析
    • By Vector Type
  • Competitive Snapshot
  • 公司简介
    • Lonza
    • Thermo Fisher Scientific Inc
    • Revvity
    • VectorBuilder Inc.
    • Creative Biolabs
    • Takara Bio Inc
    • MERCK KGaA
    • Andelyn Biosciences
    • Biovian Oy
    • Genezen
Product Code: TMRGL86344

Viral Vectors for Non-human Primates Market - Scope of Report

TMR's report on the global viral vectors for non-human primates market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global viral vectors for non-human primates market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global viral vectors for non-human primates market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the viral vectors for non-human primates market.

Market Snapshot
Market Value in 2023US$ 145.8 Mn
Market Value in 2034US$ 429.9 Mn
CAGR10.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global viral vectors for non-human primates market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global viral vectors for non-human primates market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global viral vectors for non-human primates market.

The report delves into the competitive landscape of the global viral vectors for non-human primates market. Key players operating in the global viral vectors for non-human primates market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global viral vectors for non-human primates market profiled in this report.

Key Questions Answered in Global viral vectors for non-human primates Market Report:

  • What is the sales/revenue generated by viral vectors for non-human primates across all regions during the forecast period?
  • What are the opportunities in the global viral vectors for non-human primates market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Viral Vectors for Non-human Primates Market - Research Objectives and Research Approach

The comprehensive report on the global viral vectors for non-human primates market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global viral vectors for non-human primates market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global viral vectors for non-human primates market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Viral Vectors for Non-human Primates Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Viral Vectors for Non-human Primates Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Recent Advancements in Viral Vector Technology
  • 5.2. Porter's Five Forces Analysis
  • 5.3. List of Leading CROs Offering Non-human Primate based Preclinical Testing Services
  • 5.4. PESTLE Analysis
  • 5.5. Key Industry Events (Product Approvals, Partnerships, and Collaborations)

6. Global Viral Vectors for Non-human Primates Market Analysis and Forecasts, By Vector Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Vector Type, 2020-2034
    • 6.3.1. Adenoviral Vectors
    • 6.3.2. Adeno-associated Vectors
    • 6.3.3. Retroviral Vectors
    • 6.3.4. Lentiviral Vectors
    • 6.3.5. Others
  • 6.4. Market Attractiveness By Vector Type

7. Global Viral Vectors for Non-human Primates Market Analysis and Forecasts, By Type of Non-human Primates

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Type of Non-human Primates, 2020-2034
    • 7.3.1. Marmosets
    • 7.3.2. Rhesus macaques
    • 7.3.3. Cynomolgus monkey
    • 7.3.4. Others
  • 7.4. Market Attractiveness By Type of Non-human Primates

8. Global Viral Vectors for Non-human Primates Market Analysis and Forecasts, By Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Application, 2020-2034
    • 8.3.1. Gene Therapy
    • 8.3.2. Vaccine Research
  • 8.4. Market Attractiveness By Application

9. Global Viral Vectors for Non-human Primates Market Analysis and Forecasts, By Therapeutic Area

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Therapeutic Area, 2020-2034
    • 9.3.1. Genetic Disorders
    • 9.3.2. Infectious Diseases
    • 9.3.3. Oncological Disorders
    • 9.3.4. Others
  • 9.4. Market Attractiveness By Therapeutic Area

10. Global Viral Vectors for Non-human Primates Market Analysis and Forecasts, By End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By End-user, 2020-2034
    • 10.3.1. Pharmaceutical and Biotechnology Companies
    • 10.3.2. Academic and Research Institutions
  • 10.4. Market Attractiveness By End-user

11. Global Viral Vectors for Non-human Primates Market Analysis and Forecasts, By Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast By Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness By Region

12. North America Viral Vectors for Non-human Primates Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Vector Type, 2020-2034
    • 12.2.1. Adenoviral Vectors
    • 12.2.2. Adeno-associated Vectors
    • 12.2.3. Retroviral Vectors
    • 12.2.4. Lentiviral Vectors
    • 12.2.5. Others
  • 12.3. Market Value Forecast By Type of Non-human Primates, 2020-2034
    • 12.3.1. Marmosets
    • 12.3.2. Rhesus macaques
    • 12.3.3. Cynomolgus monkey
    • 12.3.4. Others
  • 12.4. Market Value Forecast By Application, 2020-2034
    • 12.4.1. Gene Therapy
    • 12.4.2. Vaccine Research
  • 12.5. Market Value Forecast By Therapeutic Area, 2020-2034
    • 12.5.1. Genetic Disorders
    • 12.5.2. Infectious Diseases
    • 12.5.3. Oncological Disorders
    • 12.5.4. Others
  • 12.6. Market Value Forecast By End-user, 2020-2034
    • 12.6.1. Pharmaceutical and Biotechnology Companies
    • 12.6.2. Academic and Research Institutions
  • 12.7. Market Value Forecast By Country, 2020-2034
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Vector Type
    • 12.8.2. By Type of Non-human Primates
    • 12.8.3. By Application
    • 12.8.4. By Therapeutic Area
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Viral Vectors for Non-human Primates Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Vector Type, 2020-2034
    • 13.2.1. Adenoviral Vectors
    • 13.2.2. Adeno-associated Vectors
    • 13.2.3. Retroviral Vectors
    • 13.2.4. Lentiviral Vectors
    • 13.2.5. Others
  • 13.3. Market Value Forecast By Type of Non-human Primates, 2020-2034
    • 13.3.1. Marmosets
    • 13.3.2. Rhesus macaques
    • 13.3.3. Cynomolgus monkey
    • 13.3.4. Others
  • 13.4. Market Value Forecast By Application, 2020-2034
    • 13.4.1. Gene Therapy
    • 13.4.2. Vaccine Research
  • 13.5. Market Value Forecast By Therapeutic Area, 2020-2034
    • 13.5.1. Genetic Disorders
    • 13.5.2. Infectious Diseases
    • 13.5.3. Oncological Disorders
    • 13.5.4. Others
  • 13.6. Market Value Forecast By End-user, 2020-2034
    • 13.6.1. Pharmaceutical and Biotechnology Companies
    • 13.6.2. Academic and Research Institutions
  • 13.7. Market Value Forecast By Country, 2020-2034
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Spain
    • 13.7.5. Italy
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Vector Type
    • 13.8.2. By Type of Non-human Primates
    • 13.8.3. By Application
    • 13.8.4. By Therapeutic Area
    • 13.8.5. By End-user
    • 13.8.6. By Country

14. Asia Pacific Viral Vectors for Non-human Primates Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Vector Type, 2020-2034
    • 14.2.1. Adenoviral Vectors
    • 14.2.2. Adeno-associated Vectors
    • 14.2.3. Retroviral Vectors
    • 14.2.4. Lentiviral Vectors
    • 14.2.5. Others
  • 14.3. Market Value Forecast By Type of Non-human Primates, 2020-2034
    • 14.3.1. Marmosets
    • 14.3.2. Rhesus macaques
    • 14.3.3. Cynomolgus monkey
    • 14.3.4. Others
  • 14.4. Market Value Forecast By Application, 2020-2034
    • 14.4.1. Gene Therapy
    • 14.4.2. Vaccine Research
  • 14.5. Market Value Forecast By Therapeutic Area, 2020-2034
    • 14.5.1. Genetic Disorders
    • 14.5.2. Infectious Diseases
    • 14.5.3. Oncological Disorders
    • 14.5.4. Others
  • 14.6. Market Value Forecast By End-user, 2020-2034
    • 14.6.1. Pharmaceutical and Biotechnology Companies
    • 14.6.2. Academic and Research Institutions
  • 14.7. Market Value Forecast By Country, 2020-2034
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Vector Type
    • 14.8.2. By Type of Non-human Primates
    • 14.8.3. By Application
    • 14.8.4. By Therapeutic Area
    • 14.8.5. By End-user
    • 14.8.6. By Country

15. Latin America Viral Vectors for Non-human Primates Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Vector Type, 2020-2034
    • 15.2.1. Adenoviral Vectors
    • 15.2.2. Adeno-associated Vectors
    • 15.2.3. Retroviral Vectors
    • 15.2.4. Lentiviral Vectors
    • 15.2.5. Others
  • 15.3. Market Value Forecast By Type of Non-human Primates, 2020-2034
    • 15.3.1. Marmosets
    • 15.3.2. Rhesus macaques
    • 15.3.3. Cynomolgus monkey
    • 15.3.4. Others
  • 15.4. Market Value Forecast By Application, 2020-2034
    • 15.4.1. Gene Therapy
    • 15.4.2. Vaccine Research
  • 15.5. Market Value Forecast By Therapeutic Area, 2020-2034
    • 15.5.1. Genetic Disorders
    • 15.5.2. Infectious Diseases
    • 15.5.3. Oncological Disorders
    • 15.5.4. Others
  • 15.6. Market Value Forecast By End-user, 2020-2034
    • 15.6.1. Pharmaceutical and Biotechnology Companies
    • 15.6.2. Academic and Research Institutions
  • 15.7. Market Value Forecast By Country, 2020-2034
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Vector Type
    • 15.8.2. By Type of Non-human Primates
    • 15.8.3. By Application
    • 15.8.4. By Therapeutic Area
    • 15.8.5. By End-user
    • 15.8.6. By Country

16. Middle East & Africa Viral Vectors for Non-human Primates Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Vector Type, 2020-2034
    • 16.2.1. Adenoviral Vectors
    • 16.2.2. Adeno-associated Vectors
    • 16.2.3. Retroviral Vectors
    • 16.2.4. Lentiviral Vectors
    • 16.2.5. Others
  • 16.3. Market Value Forecast By Type of Non-human Primates, 2020-2034
    • 16.3.1. Marmosets
    • 16.3.2. Rhesus macaques
    • 16.3.3. Cynomolgus monkey
    • 16.3.4. Others
  • 16.4. Market Value Forecast By Application, 2020-2034
    • 16.4.1. Gene Therapy
    • 16.4.2. Vaccine Research
  • 16.5. Market Value Forecast By Therapeutic Area, 2020-2034
    • 16.5.1. Genetic Disorders
    • 16.5.2. Infectious Diseases
    • 16.5.3. Oncological Disorders
    • 16.5.4. Others
  • 16.6. Market Value Forecast By End-user, 2020-2034
    • 16.6.1. Pharmaceutical and Biotechnology Companies
    • 16.6.2. Academic and Research Institutions
  • 16.7. Market Value Forecast By Country, 2020-2034
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Vector Type
    • 16.8.2. By Type of Non-human Primates
    • 16.8.3. By Application
    • 16.8.4. By Therapeutic Area
    • 16.8.5. By End-user
    • 16.8.6. By Country

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2023)
  • 17.3. Market Footprint Analysis
    • 17.3.1. By Region
    • 17.3.2. By Vector Type
  • 17.4. Competitive Snapshot
  • 17.5. Company Profiles
    • 17.5.1. Lonza
      • 17.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.1.2. Product Portfolio
      • 17.5.1.3. Financial Overview
      • 17.5.1.4. SWOT Analysis
      • 17.5.1.5. Strategic Overview
    • 17.5.2. Thermo Fisher Scientific Inc
      • 17.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.2.2. Product Portfolio
      • 17.5.2.3. Financial Overview
      • 17.5.2.4. SWOT Analysis
      • 17.5.2.5. Strategic Overview
    • 17.5.3. Revvity
      • 17.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.3.2. Product Portfolio
      • 17.5.3.3. Financial Overview
      • 17.5.3.4. SWOT Analysis
      • 17.5.3.5. Strategic Overview
    • 17.5.4. VectorBuilder Inc.
      • 17.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.4.2. Product Portfolio
      • 17.5.4.3. Financial Overview
      • 17.5.4.4. SWOT Analysis
      • 17.5.4.5. Strategic Overview
    • 17.5.5. Creative Biolabs
      • 17.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.5.2. Product Portfolio
      • 17.5.5.3. Financial Overview
      • 17.5.5.4. SWOT Analysis
      • 17.5.5.5. Strategic Overview
    • 17.5.6. Takara Bio Inc
      • 17.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.6.2. Product Portfolio
      • 17.5.6.3. Financial Overview
      • 17.5.6.4. SWOT Analysis
      • 17.5.6.5. Strategic Overview
    • 17.5.7. MERCK KGaA
      • 17.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.7.2. Product Portfolio
      • 17.5.7.3. Financial Overview
      • 17.5.7.4. SWOT Analysis
      • 17.5.7.5. Strategic Overview
    • 17.5.8. Andelyn Biosciences
      • 17.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.8.2. Product Portfolio
      • 17.5.8.3. Financial Overview
      • 17.5.8.4. SWOT Analysis
      • 17.5.8.5. Strategic Overview
    • 17.5.9. Biovian Oy
      • 17.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.9.2. Product Portfolio
      • 17.5.9.3. Financial Overview
      • 17.5.9.4. SWOT Analysis
      • 17.5.9.5. Strategic Overview
    • 17.5.10. Genezen
      • 17.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.5.10.2. Product Portfolio
      • 17.5.10.3. Financial Overview
      • 17.5.10.4. SWOT Analysis
      • 17.5.10.5. Strategic Overview

List of Tables

  • Table 1: Global Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Vector Type, 2020-2034
  • Table 2: Global Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Type of Non-human Primates, 2020-2034
  • Table 3: Global Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 4: Global Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 5: Global Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 6: Global Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 7: North America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 8: North America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Vector Type, 2020-2034
  • Table 9: North America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Type of Non-human Primates, 2020-2034
  • Table 10: North America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 11: North America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 12: North America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 13: Europe Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Europe Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Vector Type, 2020-2034
  • Table 15: Europe Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Type of Non-human Primates, 2020-2034
  • Table 16: Europe Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 17: Europe Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 18: Europe Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 19: Europe Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 20: Asia Pacific Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 21: Asia Pacific Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Vector Type, 2020-2034
  • Table 22: Asia Pacific Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Type of Non-human Primates, 2020-2034
  • Table 23: Asia Pacific Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 24: Asia Pacific Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 25: Asia Pacific Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 26: Latin America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Latin America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Vector Type, 2020-2034
  • Table 28: Latin America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Type of Non-human Primates, 2020-2034
  • Table 29: Latin America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 30: Latin America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 31: Latin America Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 32: Middle East & Africa Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 33: Middle East & Africa Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Vector Type, 2020-2034
  • Table 34: Middle East & Africa Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Type of Non-human Primates, 2020-2034
  • Table 35: Middle East & Africa Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 36: Middle East & Africa Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 37: Middle East & Africa Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 1: Global Viral Vectors for Non-human Primates Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 2: Global Viral Vectors for Non-human Primates Market Value Share, by Vector Type, 2023
  • Figure 3: Global Viral Vectors for Non-human Primates Market Value Share, by Type of Non-human Primates, 2023
  • Figure 4: Global Viral Vectors for Non-human Primates Market Value Share, by Application, 2023
  • Figure 5: Global Viral Vectors for Non-human Primates Market Value Share, by Therapeutic Area, 2023
  • Figure 6: Global Viral Vectors for Non-human Primates Market Value Share, by End-user, 2023
  • Figure 7: Global Viral Vectors for Non-human Primates Market Value Share, by Region, 2023
  • Figure 8: Global Viral Vectors for Non-human Primates Market Value (US$ Mn) Share Analysis, by Vector Type, 2023 and 2034
  • Figure 9: Global Viral Vectors for Non-human Primates Market Share Analysis, by Vector Type, 2023
  • Figure 10: Global Viral Vectors for Non-human Primates Market Share Analysis, by Vector Type, 2034
  • Figure 11: Global Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Vector Type, 2024-2034
  • Figure 12: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Adenoviral Vectors, 2020-2034
  • Figure 13: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Adenoviral Vectors, 2023 and 2034
  • Figure 14: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Adeno-associated Vectors, 2020-2034
  • Figure 15: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Adeno-associated Vectors, 2023 and 2034
  • Figure 16: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Retroviral, 2020-2034
  • Figure 17: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Retroviral, 2023 and 2034
  • Figure 18: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Others, 2020-2034
  • Figure 19: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 20: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Others, 2020-2034
  • Figure 21: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 22: Global Viral Vectors for Non-human Primates Market Value (US$ Mn) Share Analysis, by Type of Non-human Primates, 2023 and 2034
  • Figure 23: Global Viral Vectors for Non-human Primates Market Share Analysis, by Type of Non-human Primates, 2023
  • Figure 24: Global Viral Vectors for Non-human Primates Market Share Analysis, by Type of Non-human Primates, 2034
  • Figure 25: Global Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primates, 2024-2034
  • Figure 26: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Marmosets, 2020-2034
  • Figure 27: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Marmosets, 2023 and 2034
  • Figure 28: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Rhesus Macaques, 2020-2034
  • Figure 29: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Rhesus Macaques, 2020-2034
  • Figure 30: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Cynomolgus monkey, 2020-2034
  • Figure 31: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Cynomolgus Monkey, 2023 and 2034
  • Figure 32: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Others, 2020-2034
  • Figure 33: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 34: Global Viral Vectors for Non-human Primates Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 35: Global Viral Vectors for Non-human Primates Market Share Analysis, by Application, 2023
  • Figure 36: Global Viral Vectors for Non-human Primates Market Share Analysis, by Application, 2034
  • Figure 37: Global Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 38: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Gene Therapy, 2020-2034
  • Figure 39: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Gene Therapy, 2023 and 2034
  • Figure 40: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Vaccine Research, 2020-2034
  • Figure 41: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Vaccine Research, 2023 and 2034
  • Figure 42: Global Viral Vectors for Non-human Primates Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 43: Global Viral Vectors for Non-human Primates Market Share Analysis, by Therapeutic Area, 2023
  • Figure 44: Global Viral Vectors for Non-human Primates Market Share Analysis, by Therapeutic Area, 2034
  • Figure 45: Global Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 46: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Genetic Disorders, 2020-2034
  • Figure 47: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Genetic Disorders, 2023 and 2034
  • Figure 48: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Infectious Diseases, 2020-2034
  • Figure 49: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Infectious Diseases, 2023 and 2034
  • Figure 50: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Oncological Disorder, 2020-2034
  • Figure 51: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Oncological Disorder, 2023 and 2034
  • Figure 52: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Others, 2020-2034
  • Figure 53: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 54: Global Viral Vectors for Non-human Primates Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 55: Global Viral Vectors for Non-human Primates Market Share Analysis, by End-user, 2023
  • Figure 56: Global Viral Vectors for Non-human Primates Market Share Analysis, by End-user, 2034
  • Figure 57: Global Viral Vectors for Non-human Primates Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 58: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Pharmaceutical and Biotechnology Companies, 2020-2034
  • Figure 59: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Pharmaceutical and Biotechnology Companies, 2023 and 2034
  • Figure 60: Global Viral Vectors for Non-human Primates Market Value (US$ Mn), by Academic and Research Institutions, 2020-2034
  • Figure 61: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Academic and Research Institutions, 2023 and 2034
  • Figure 62: Global Viral Vectors for Non-human Primates Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 63: Global Viral Vectors for Non-human Primates Market Share Analysis, by Region, 2023
  • Figure 64: Global Viral Vectors for Non-human Primates Market Share Analysis, by Region, 2034
  • Figure 65: Global Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 66: North America Viral Vectors for Non-human Primates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: North America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 68: North America Viral Vectors for Non-human Primates Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 69: North America Viral Vectors for Non-human Primates Market Value Share Analysis, by Vector Type, 2023 and 2034
  • Figure 70: North America Viral Vectors for Non-human Primates Market Value Share Analysis, by Type of Non-human Primates, 2023 and 2034
  • Figure 71: North America Viral Vectors for Non-human Primates Market Value Share Analysis, by Application 2023 and 2034
  • Figure 72: North America Viral Vectors for Non-human Primates Market Value Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 73: North America Viral Vectors for Non-human Primates Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 74: North America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Vector Type, 2024-2034
  • Figure 75: North America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primates, 2024-2034
  • Figure 76: North America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 77: North America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 78: North America Viral Vectors for Non-human Primates Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 79: Europe Viral Vectors for Non-human Primates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 80: Europe Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 81: Europe Viral Vectors for Non-human Primates Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 82: Europe Viral Vectors for Non-human Primates Market Value Share Analysis, by Vector Type, 2023 and 2034
  • Figure 83: Europe Viral Vectors for Non-human Primates Market Value Share Analysis, by Type of Non-human Primates, 2023 and 2034
  • Figure 84: Europe Viral Vectors for Non-human Primates Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 85: Europe Viral Vectors for Non-human Primates Market Value Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 86: Europe Viral Vectors for Non-human Primates Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 87: Europe Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Vector Type, 2024-2034
  • Figure 88: Europe Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primates, 2024-2034
  • Figure 89: Europe Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 90: Europe Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 91: Europe Viral Vectors for Non-human Primates Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 92: Asia Pacific Viral Vectors for Non-human Primates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 93: Asia Pacific Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 94: Asia Pacific Viral Vectors for Non-human Primates Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 95: Asia Pacific Viral Vectors for Non-human Primates Market Value Share Analysis, by Vector Type, 2023 and 2034
  • Figure 96: Asia Pacific Viral Vectors for Non-human Primates Market Value Share Analysis, by Type of Non-human Primates, 2023 and 2034
  • Figure 97: Asia Pacific Viral Vectors for Non-human Primates Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 98: Asia Pacific Viral Vectors for Non-human Primates Market Value Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 99: Asia Pacific Viral Vectors for Non-human Primates Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 100: Asia Pacific Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Vector Type, 2024-2034
  • Figure 101: Asia Pacific Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primates, 2024-2034
  • Figure 102: Asia Pacific Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 103: Asia Pacific Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2023-2034
  • Figure 104: Asia Pacific Viral Vectors for Non-human Primates Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 105: Latin America Viral Vectors for Non-human Primates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 106: Latin America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 107: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 108: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by Vector Type, 2023 and 2034
  • Figure 109: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by Type of Non-human Primates, 2023 and 2034
  • Figure 110: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 111: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 112: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 113: Latin America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Vector Type, 2024-2034
  • Figure 114: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by Type of Non-human Primates, 2023 and 2034
  • Figure 115: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 116: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 117: Latin America Viral Vectors for Non-human Primates Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 118: Latin America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Vector Type, 2024-2034
  • Figure 119: Latin America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primates, 2024-2034
  • Figure 120: Latin America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 121: Latin America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 122: Latin America Viral Vectors for Non-human Primates Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 123: Middle East & Africa Viral Vectors for Non-human Primates Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 124: Middle East & Africa Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 125: Middle East & Africa Viral Vectors for Non-human Primates Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 126: Middle East & Africa Viral Vectors for Non-human Primates Market Value Share Analysis, by Vector Type, 2023 and 2034
  • Figure 127: Middle East & Africa Viral Vectors for Non-human Primates Market Value Share Analysis, by Type of Non-human Primates, 2023 and 2034
  • Figure 128: Middle East & Africa Viral Vectors for Non-human Primates Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 129: Middle East & Africa Viral Vectors for Non-human Primates Market Value Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 130: Middle East & Africa Viral Vectors for Non-human Primates Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 131: Middle East & Africa Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Vector Type, 2024-2034
  • Figure 132: Middle East & Africa Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Type of Non-human Primates, 2024-2034
  • Figure 133: Middle East & Africa Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 134: Middle East & Africa Viral Vectors for Non-human Primates Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 135: Middle East & Africa Viral Vectors for Non-human Primates Market Attractiveness Analysis, by End-user, 2024-2034